The research field of 'cellular IRESes' lay dormant for decades, as there was no uniform standard of reliable methods for the clear characterization of these starting points for the ribosome-mediated ...
Only recently has the ribosome—one of the oldest molecular machines in evolutionary terms—been recognized as an active ...
Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...
And sometimes you can find stocks that are especially great bargains. Three Motley Fool contributors believe they've done just that. Here's ...
MODERNA INC (MRNA) is a large-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 86% based on the firm’s underlying fundamentals and the stock’s valuation.
Venice, Italy-based Officinae Bio's proprietary digital platform accelerates the prototyping of mRNA drug candidates, enabling the rapid testing of diverse combinations of capping analogs ...
News Medical on MSN2d
Starting points for the control of protein synthesis / Bonn researchers develop a versatile toolbox for the characterization of IRESes in cellsThe research field of "cellular IRESes" lay dormant for decades, as there was no uniform standard of reliable methods for the ...
circular mRNA vaccines will become significantly cheaper to produce, with up to 90% lower manufacturing cost, as they circumvent the need to use modified nucleotide analogues, and no 5´capping is ...
BioNTech is expanding its oncology pipeline with FixVac, iNeST, and BNT327 for individualized cancer treatments. Read why I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback